American pharmaceutical company Pfiza, one of the world leaders in this industry, from January to September 2018, increased its net profit by 28% in annual terms to 11 billion 546 million dollars, finversia.ru writes, referring to the company's statements. Earnings per share rose to 1 dollar 92 cents from 1 dollar 49 cents a year earlier. Revenue increased by 2% and amounted to 39 billion 700 million dollars. In the third quarter, Pfiza net profit increased 1.5 times, and its revenue increased by 1%. At the same time, in the sector of basic medical goods and services a decrease by 4% was observed.
BOJ offers $78 billion in loan to virus-hit firms in first phase of lending program10.06.2020
Global airlines heading for $84 billion net loss in 2020: IATA05.06.2020
Gap reports nearly $1 billion first-quarter loss amid the virus outbreak03.06.2020
Chinese services industry posts first growth since January, job losses persist according to study